Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Strategies in Trauma and Limb Reconstruction is Scopus-indexed (Q3, CiteScore 2.2), WoS ESCI. Published by Jaypee Brothers Medical Publishers (P) Ltd.
Checked against the index lists dated .
ISSN 1828-8928Verify ISSN ↗1828-8936Verify ISSN ↗
Publisher: Jaypee Brothers Medical Publishers (P) Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Orthopedics and Sports Medicine | 200 / 340 | 41st | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2007–2025, best quartile Q3, CiteScore 2.2.
Strategies in Trauma and Limb Reconstruction is Q3 in Orthopedics and Sports Medicine (rank 200 of 340), by CiteScore 2025.
Strategies in Trauma and Limb Reconstruction is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.2, which places it in quartile Q3 at the 41st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.395, quartile Q3, with an H-index of 37.
Strategies in Trauma and Limb Reconstruction is published by Jaypee Brothers Medical Publishers (P) Ltd. Its print ISSN is 1828-8928 and its online ISSN is 1828-8936.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Strategies in Trauma and Limb Reconstruction has an h-index of 46 and a 2-year mean of 1.2 citations per paper (OpenAlex). Its Scopus CiteScore is 2.2, quartile Q3. On 2-year citations it ranks #175 of 331 Scopus journals in Orthopedics and Sports Medicine.
Strategies in Trauma and Limb Reconstruction published 20 papers in 2025; its busiest recent year was 2022 with 41. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2022–2026), authors are most often from United Kingdom (33.3%), United States (16.3%) and India (5.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.